Dr. Bill Stoops

William Stoops, PhD, was named the 2024 Researcher of the Year by the Kentucky Psychological Association (KPA) in recognition of his service to psychology and outstanding academic record. 

The University of Kentucky鈥檚 Substance Use Priority Research Area (SUPRA) is sponsoring the inaugural Rising Stars Symposium to showcase innovative research and new perspectives on addiction research.

Tom Arkell and the Cannabis Center logo

The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science.

Justin Ma presents his poster

At the 好色先生 College of Medicine, we embrace our responsibility to drive the change and the discovery required to improve health and wellness across the state. As a recognized leader in biomedical research, we focus on innovative, transformative, and collaborative discoveries from the bench to the bedside.

Monica Bertagnolli at a podium, addressing a University of Kentucky audience.

Much of the research conducted at the University of Kentucky focuses on addressing key health challenges facing the Commonwealth from cancer to substance use.

Group of award winners

The 好色先生 is excited to share the winners of the third annual Mission, Vision, Pillar, and Enabler (MVPE) Awards.

An auditorium for the SURE presentations.

The University of Kentucky has set the date for its sixth annual Substance Use Research Event (SURE) and registration is currently open.

Kelly Young-Wolff and the Cannabis Center Seminar Series logo

The University of Kentucky Cannabis Center is sponsoring a seminar series featuring national and international experts on cannabis science.

GME winners

The following individuals were honored at the 好色先生 Awards Convocation on Wednesday, Oct. 18, 2023. Winners included those in Bowling Green, Lexington, Morehead, and Northern Kentucky.

Biomedical Education

Outstanding Graduate Student Award:
Jamila Tucker, MS

From left to right: Dr. Rachel Wilson, Lisa Williams, Renee Gallagher, and LeAnn Barber

Burnout is a problem in any profession, but it is rampant in health care. This national problem has been evident recently as the COVID-19 pandemic pushed many learners, practitioners, faculty, and staff to the limit.

LaTrice Montgomery, PhD and Cannabis Center logo

The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science.

Stock photo of woman on computer

The 好色先生 is excited to announce that faculty, staff, learners, and trainees will have free access to a leading online resource for medical Spanish proficiency.

CanopyLearn, a Spanish language training program for health care professionals, will be available to the 好色先生 College of Medicine community starting Aug. 1.

Headshot of Dr. Na'Tasha Evans

Na鈥橳asha Evans, PhD, MEd, is a researcher, published author, champion for female empowerment, and our new vice dean for diversity, equity, and inclusion at the 好色先生. Learn more about her goals, her past work, and more in the following Q&A.

Q: What inspired you to pursue a career in research? 

Ashley Brooks-Russell, PhD and the Cannabis Center logo

The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science.

Scientist working with a small portion of cannabis.

The University of Kentucky is home to a new center that will advance research on the medical use of cannabis.

The 好色先生 Cannabis Center will conduct research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions.

190408Lofwall6355.JPG

After being revived with Naloxone in the emergency room, patients immediately enter withdrawal. Cold chills, vomiting, diarrhea 鈥 鈥渄ope sickness鈥 is what many call it. The feeling is hard to describe, but many people who鈥檝e experienced it or witnessed it say it鈥檚 like the worst flu times 10.

Michelle Lofwall and Implant.JPG

A multi-site clinical trial led by researchers at the University of Kentucky Center on Drug and Alcohol Research (CDAR) has demonstrated the effectiveness of CAM2038, a potentially transformative buprenorphine therapy for moderate-to-severe opioid use disorders.

michelle_lofwall_and_implant.jpg

Even with the assistance of detoxification and rehabilitation programs, 80 percent of people attempting recovery from opioid addiction will relapse.

The firm grip of opioid addiction on a person鈥檚 life necessitates sustainable therapeutic approaches proven effective through scientific trials and evidence.